Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00897338 · ClinicalTrials.gov registry record
Identifying Circulating Breast Cancer Cells in Women With Metastatic Breast Cancer
A clinical trial, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- Completed
- Registry status
- 43
- Enrollment target
NCT00897338 is a clinical trial that has completed, run by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. The registered enrollment target is 43 participants.
The verdict
NCT00897338 has completed, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- COMPLETED
- Registry status
- 43 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of blood and pleural or peritoneal fluid from patients with metastatic breast cancer in the laboratory may help doctors identify biomarkers related to breast cancer and learn more about how breast cancer begins and spreads in the body. PURPOSE: This research study is looking at a new way of identifying circulating breast cancer cells in blood and in pleural or peritoneal fluid in women with metastatic breast cancer.
Interventions
- OTHER immunohistochemistry staining method
- OTHER flow cytometry
- OTHER immunologic technique
- OTHER fluorescence activated cell sorting
- OTHER biomarker analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2007-08 |
| Est. Completion | 2014-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00897338
The ClinicalTrials.gov registry entry for NCT00897338 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which immunohistochemistry staining method is the first listed.
NCT00897338 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00897338 about?
NCT00897338 is a clinical study titled "Identifying Circulating Breast Cancer Cells in Women With Metastatic Breast Cancer". RATIONALE: Studying samples of blood and pleural or peritoneal fluid from patients with metastatic breast cancer in the laboratory may help doctors identify biomarkers related to breast cancer and learn more about how breast cancer begins and spreads in the body. PURPOSE: This research study is loo...
What is the current status of trial NCT00897338?
This trial is currently completed. The enrollment target is 43 participants. The study started on 2007-08. Estimated completion is 2014-01.
What interventions are being tested in trial NCT00897338?
The interventions under investigation include: immunohistochemistry staining method (OTHER), flow cytometry (OTHER), immunologic technique (OTHER), fluorescence activated cell sorting (OTHER), biomarker analysis (OTHER).
Who is sponsoring clinical trial NCT00897338?
This trial is sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.